Munder Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Munder Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$6K	Hold	120	–	–	﹤0.01%	643
2014 Q2	$6K	Hold	120	–	–	﹤0.01%	650
2014 Q1	$6K	Hold	120	–	–	﹤0.01%	654
2013 Q4	$6K	Hold	120	–	–	﹤0.01%	642
2013 Q3	$6K	Hold	120	–	–	﹤0.01%	635
2013 Q2	$5K	Buy	+120	New	+$5.21K	﹤0.01%	644

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Munder Capital Management's BMY Position: Q3 2014 in Review

Munder Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2014 at 120 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #643.

Munder Capital Management first reported a position in BMY in Q2 2013 and has held it in 6 quarters since. 1,301 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

Munder Capital Management held 120 shares of Bristol-Myers Squibb worth $6K as of Q3 2014.
Munder Capital Management left its Bristol-Myers Squibb share count unchanged in Q3 2014.
Bristol-Myers Squibb made up ﹤0.01% of Munder Capital Management's portfolio in Q3 2014, its #643 holding.
Munder Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 6 quarters since.
1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.